Cathryn M. Clary

Chief Scientific Officer at Novartis Pharmaceuticals Corp.

Cathryn M. Clary

Cathryn M. Clary

Chief Scientific Officer at Novartis Pharmaceuticals Corp.

Overview
RelSci Relationships

1100

Number of Boards

2

Relationships
RelSci Relationships are individuals Cathryn M. Clary likely has professional access to. A relationship does not necessarily indicate a personal connection.

Director at Assn. for Accred. of Human Research Protection Programs, Inc.

Relationship likelihood: Strong

Director at Assn. for Accred. of Human Research Protection Programs, Inc.

Relationship likelihood: Strong

Director at Assn. for Accred. of Human Research Protection Programs, Inc.

Relationship likelihood: Strong

Vice Chair at Assn. for Accred. of Human Research Protection Programs, Inc.

Relationship likelihood: Strong

Secretary at Assn. for Accred. of Human Research Protection Programs, Inc.

Relationship likelihood: Strong

Venture Partner at Tullis Health Investors, Inc.

Relationship likelihood: Strong

Former Chief Financial Officer & Executive Vice President at Novartis Corporation

Relationship likelihood: Strong

Vice President & General Counsel at Ipsen, Inc.

Relationship likelihood: Strong

Dean Emeritus at California Western School of Law

Relationship likelihood: Strong

Chief Medical Officer & Senior Vice President at ACADIA Pharmaceuticals, Inc.

Relationship likelihood: Strong

Paths to Cathryn M. Clary
Potential Connections via
Relationship Science
You
Cathryn M. Clary
Chief Scientific Officer at Novartis Pharmaceuticals Corp.
Education

University of Missouri was founded in 1839 in Columbia, Missouri. MU is a major land-grant institution and Missouri's largest public research university. It is one of only 34 public universities, and the only public institution in Missouri, to be selected for membership in the Association of American Universities. MU offers more than 280 degree programs including more than 75 online degree options and is designated as comprehensive doctoral with medical/veterinary by the Carnegie Foundation for the Advancement of Teaching.

Bryn Mawr is one of the world's most distinctive, distinguished colleges. Every year 1,300 undergraduate women and 400 graduate students from around the world gather on the College's historic campus to study with leading scholars, conduct advanced research, and expand the boundaries of what's possible.

The University of Delaware (UD) is a state-assisted, privately governed institution that was founded in 1743. It offers 3 associate programs, 147 bachelor’s programs, 119 master's programs, 54 doctoral programs, and 15 dual graduate programs through seven colleges and in collaboration with more than 70 research centers. UD's student body encompasses more than 17,000 undergraduates, more than 3,600 graduate students and nearly 800 students in professional and continuing studies from across the country and around the globe. The University received its charter from the State of Delaware in 1833 and was designated one of the nation’s historic Land Grant colleges in 1867. Today, UD is a Land Grant, Sea Grant and Space Grant institution. The Carnegie Foundation for the Advancement of Teaching classifies UD as a research university with very high research activity—a designation accorded less than 3 percent of U.S. colleges and universities. UD ranks among the nation’s top 100 universities in federal R&D support for science and engineering.

Memberships
Member
Current

To further the interests of the medical profession by promoting the art and science of medicine and the betterment of public health.

Member
Current

American Academy of Neurology operates a professional society which represents neurologists and neuroscientists. The company was founded in 1948 and is headquartered in Minneapolis, MN.

Career History
Senior Vice President-Medical & Regulatory Affairs
Current

Ipsen, Inc. design and manufacture of industrial atmosphere and vacuum heat-treating systems and supervisory controls systems. It offers vacuum furnaces, atmosphere furnaces, and PdMetrics software platform. The company was founded by Harold Ipsen in 1948 and is headquartered in Cherry Valley, IL.

Chief Scientific Officer
2012 - Current

Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.

Boards & Committees
Director
Tenure Unconfirmed

THE PURPOSE OF THE FOUNDATION IS TO ASSIST AND SUPPORT THE AMERICAN PSYCHIATRIC ASSOCIATION IN ACCOMPLISHING ITS EDUCATIONAL AND SCIENTIFIC PURPOSES BY PERFORMING FUNDRAISING FUNCTIONS AND BY DEVELOPING PUBLIC AND PROFESSIONAL ACTIVITIES TO ADVANCE EDUCATION IN MENTAL HEALTH AND PSYCHIATRIC DISORDERS, AND RELATED MENTAL HEALTH SUBJECTS AND TO PROMOTE THE TREATMENT OF PSYCHIATRIC ILLNESS.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$100 - $249
2016

ADVANCING RESEARCH, ACCELERATED DIAGNOSIS, OPTIMUM TREATMENT, PUBLIC AWARENESS, AND HEALTH CARE

$100 - $249
2015

ADVANCING RESEARCH, ACCELERATED DIAGNOSIS, OPTIMUM TREATMENT, PUBLIC AWARENESS, AND HEALTH CARE

$100 - $249
2011

ADVANCING RESEARCH, ACCELERATED DIAGNOSIS, OPTIMUM TREATMENT, PUBLIC AWARENESS, AND HEALTH CARE

Political Donations
$500
2011

Former President of United States

$250
1995

Former President of United States

$500
1994

United States Attorney for the District of Delaware at United States Department of Justice

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cathryn M. Clary. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cathryn M. Clary's profile does not indicate a business or promotional relationship of any kind between RelSci and Cathryn M. Clary.